Summary:
In patients with type 2 diabetes, personalized exercise prescription based on the Chester Step Test (CST) significantly reduced glycemic variability compared to standard care under free-living conditions, though it was associated with no significant adverse side effects reported.
| PICO | Description |
|---|---|
| Population | Patients diagnosed with type 2 diabetes mellitus (T2D) managing glycemic control under free-living conditions. |
| Intervention | Personalized exercise prescription developed using the Chester Step Test (CST) to tailor physical activity. |
| Comparison | Standard diabetes care without individualized exercise plans or generic exercise recommendations under free-living conditions. |
| Outcome | The intervention group demonstrated a significant reduction in glycemic variability, indicating improved glucose stability. No major adverse effects related to the exercise prescription were reported. |
Source: Chen Wang, et al. “Clinical application of Chester Step Test in developing personalized exercise prescription in patients with type 2 diabetes: A single-blind, randomized controlled trial.” Read article here.
